From July 1, 2022 to September 30, 2022, the company has repurchased 1,494,017 shares, representing 1.39% for $913.32 million. With this, the company has completed the repurchase of 2,965,289 shares, representing 2.77% for $1,813.87 million under the buyback announced on November 12, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
957 USD | +2.07% | +8.36% | +8.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B | |
-24.53% | 8.26B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 12, 2021.